PMS-METHOTREXATE INJECTION
PHARMASCIENCE INC
Quick answers
Is there a shortage of PMS-METHOTREXATE INJECTION in Canada?
No. There is no current shortage of PMS-METHOTREXATE INJECTION 17.5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
METHOTREXATE INJECTION USP
PFIZER CANADA ULC
METHOTREXATE SODIUM INJECTION USP
PFIZER CANADA ULC
METHOTREXATE INJECTION, BP
PHARMASCIENCE INC
METOJECT
MEDEXUS PHARMACEUTICALS INC.
METHOTREXATE PF/SA INJECTION
SANDOZ CANADA INCORPORATED
METOJECT SUBCUTANEOUS
MEDEXUS PHARMACEUTICALS INC.
DIN
02539632
Strength
17.5MG
Dosage Form
Solution
Route
Subcutaneous
Active Ingredient
METHOTREXATE (METHOTREXATE SODIUM)
See all METHOTREXATE (METHOTREXATE SODIUM) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from PHARMASCIENCE INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02303299
DIN 01999648
DIN 01999656
DIN 02028174
DIN 02025337
650MG · DIN 02527901
81MG · DIN 02433044
81MG · DIN 02244993
81MG · DIN 02394790
80MG · DIN 02009013
80MG · DIN 02238545
40MG · DIN 02399393